Institute for Neuro Immune Medicine

The Institute for Neuro-Immune Medicine (INIM), at Nova Southeastern University in Fort Lauderdale, Florida, United States, is led by Nancy Klimas, MD.

Notable people

 * Nancy Klimas, Director of INIM and Chair of Clinical Immunology at Nova Southeastern University
 * Amanpreet Cheema PhD, Director, Division of Clinical Research [1]
 * Irma Rey, MD
 * Irina Rozenfeld, DNP, ARNP
 * Annette Fornos, MD
 * Violetta Rozenfeld, DNP, ARNP
 * Mary Ann Fletcher (retired), Schemel Professor for Neuro Immune Medicine
 * Fanny Collado, Research Nurse Coordinator and Health Science Specialist

Notable studies

 * 2018, Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns

Crowd-sourced ME/CFS Gene Study
Beginning in 2015, Dr. Klimas has asked patients to provide their genetic data (either via Ancestry.com or 23andMe) to develop a large-scale study to look for patterns and subgroups in the genetics of ME/CFS patients.

ME/CFS Detecting Myotoxin Subgroup
This is a pilot study to look at mycotoxins (toxic metabolites produced by molds/fungi) in patients with ME/CFS. It aims to:
 * find out whether the Environmental Exposure Questionnaire (EEQ) can be used to assess for mycotoxin exposure in ME/CFS patients
 * assess if the mycotoxin exposure results in more severe symptoms in ME/CFS patients
 * future studies will use the blood samples collected to discover if there is a "specific immune or metabolic dysfunction, or epigenetic changes" related to mycotoxin exposure in ME/CFS patients

Clinical Nutrition Profile for ME/CFS
The Clinical Nutrition Profile (CNP) project aims to create a profile of people with ME/CFS based on nutritional biomarkers, their dietary intake and other clinically relevant data. By investigating nutritional patterns and deficiencies associated with the ME/CFS it could help "identifying disease targets, improving overall organ system function, allowing body to heal and potentially resetting homeostatic function" to improve patient response to current treatments.

Online presence

 * Website
 * Twitter
 * Facebook
 * YouTube
 * Location: